Utility of PCR in Patients with Strongyloides stercoralis and HTLV-1 Coinfection in French Guiana. 2019

Romain Blaizot, and Stephane Simon, and Jean Brottier, and Denis Blanchet, and Paul Brousse, and Rachida Boukhari, and Magalie Demar
EA 3593, Ecosystèmes Amazoniens et Pathologies Tropicales, Université de Guyane, Cayenne, French Guiana.

Strongyloides stercoralis and human T-lymphotropic virus 1 (HTLV-1) coinfections have been extensively reported in the literature, but the diagnosis and treatment of strongyloidiasis remains a challenge, particularly in HTLV-1 carriers. Our objectives were to evaluate the efficacy of a new PCR method for the detection of S. stercoralis in HTLV-1-positive patients. Stools were collected over a 1-year period across the endemic region of French Guiana, including remote forest areas. Two systems of real-time PCR were then used comparatively, with small subunit and specific repeat as respective targets, and compared with the results of microscopic examinations. One-hundred and twelve stool samples were included. Twenty-seven patients (24.1%) presented a positive HTLV-1 serology. The overall prevalence of strongyloidiasis among the 112 patients was 30% with small-subunit PCR and 11.6% with microscopic examinations. In the seropositive population, all tested stools were negative, whereas 51.2% were positive using small-subunit PCR. Thus, PCR allowed a much-improved sensitivity, particularly in HTLV-1 carriers. Among the two systems investigated, small subunit yielded better results than specific repeat PCR, with prevalence rates in HTLV-1 carriers of 51.2% and 22.2%, respectively. Therefore, PCR should be considered as a useful tool for the diagnosis of strongyloidiasis, particularly in HTLV-1 carriers who often present a light parasitic load due to erratic administration of anthelmintic drugs.

UI MeSH Term Description Entries
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005616 French Guiana A French overseas department on the northeast coast of South America. Its capital is Cayenne. It was first settled by the French in 1604. Early development was hindered because of the presence of a penal colony. The name of the country and the capital are variants of Guyana, possibly from the native Indian Guarani guai (born) + ana (kin), implying a united and interrelated race of people. (From Webster's New Geographical Dictionary, 1988, p418 & Room, Brewer's Dictionary of Names, 1992, p195)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000871 Anthelmintics Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. Anthelmintic,Antihelmintic,Vermifuge,Vermifuges,Antihelmintics
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013322 Strongyloidiasis Infection with nematodes of the genus STRONGYLOIDES. The presence of larvae may produce pneumonitis and the presence of adult worms in the intestine could lead to moderate to severe diarrhea. Anguilluliasis,Anguilluliases,Strongyloidiases
D015342 DNA Probes Species- or subspecies-specific DNA (including COMPLEMENTARY DNA; conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections. Chromosomal Probes,DNA Hybridization Probe,DNA Probe,Gene Probes, DNA,Conserved Gene Probes,DNA Hybridization Probes,Whole Chromosomal Probes,Whole Genomic DNA Probes,Chromosomal Probes, Whole,DNA Gene Probes,Gene Probes, Conserved,Hybridization Probe, DNA,Hybridization Probes, DNA,Probe, DNA,Probe, DNA Hybridization,Probes, Chromosomal,Probes, Conserved Gene,Probes, DNA,Probes, DNA Gene,Probes, DNA Hybridization,Probes, Whole Chromosomal
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I

Related Publications

Romain Blaizot, and Stephane Simon, and Jean Brottier, and Denis Blanchet, and Paul Brousse, and Rachida Boukhari, and Magalie Demar
March 2022, Biomedica : revista del Instituto Nacional de Salud,
Romain Blaizot, and Stephane Simon, and Jean Brottier, and Denis Blanchet, and Paul Brousse, and Rachida Boukhari, and Magalie Demar
August 2011, Bulletin de la Societe de pathologie exotique (1990),
Romain Blaizot, and Stephane Simon, and Jean Brottier, and Denis Blanchet, and Paul Brousse, and Rachida Boukhari, and Magalie Demar
June 2000, Medicina clinica,
Romain Blaizot, and Stephane Simon, and Jean Brottier, and Denis Blanchet, and Paul Brousse, and Rachida Boukhari, and Magalie Demar
January 2020, Interdisciplinary perspectives on infectious diseases,
Romain Blaizot, and Stephane Simon, and Jean Brottier, and Denis Blanchet, and Paul Brousse, and Rachida Boukhari, and Magalie Demar
April 1993, The American journal of medicine,
Romain Blaizot, and Stephane Simon, and Jean Brottier, and Denis Blanchet, and Paul Brousse, and Rachida Boukhari, and Magalie Demar
January 2004, Parasite immunology,
Romain Blaizot, and Stephane Simon, and Jean Brottier, and Denis Blanchet, and Paul Brousse, and Rachida Boukhari, and Magalie Demar
September 2003, Clinical and experimental immunology,
Romain Blaizot, and Stephane Simon, and Jean Brottier, and Denis Blanchet, and Paul Brousse, and Rachida Boukhari, and Magalie Demar
January 1989, The New England journal of medicine,
Romain Blaizot, and Stephane Simon, and Jean Brottier, and Denis Blanchet, and Paul Brousse, and Rachida Boukhari, and Magalie Demar
January 1997, Medecine tropicale : revue du Corps de sante colonial,
Romain Blaizot, and Stephane Simon, and Jean Brottier, and Denis Blanchet, and Paul Brousse, and Rachida Boukhari, and Magalie Demar
January 1999, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru,
Copied contents to your clipboard!